CLEARMIND MEDICINE INC (CMND) Stock Price & Overview
NASDAQ:CMND • CA1850535016
Current stock price
The current stock price of CMND is 1.08 USD. Today CMND is down by 0%. In the past year, price decreased by -97.38%.
CMND Key Statistics
- Market Cap
- 1.62M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -24.40
- Dividend Yield
- N/A
CMND Stock Performance
CMND Stock Chart
CMND Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CMND. When comparing the yearly performance of all stocks, CMND is a bad performer in the overall market: 98.18% of all stocks are doing better.
CMND Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CMND. CMND scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CMND Earnings
CMND Forecast & Estimates
CMND Groups
Sector & Classification
CMND Financial Highlights
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -24.4. The EPS increased by 53.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -167.27% | ||
| ROE | -623.06% | ||
| Debt/Equity | 0 |
CMND Ownership
CMND Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.76 | 900.456B | ||
| JNJ | JOHNSON & JOHNSON | 20.87 | 587.99B | ||
| MRK | MERCK & CO. INC. | 23.36 | 298.764B | ||
| PFE | PFIZER INC | 9.48 | 162.403B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.41 | 125.711B | ||
| ZTS | ZOETIS INC | 16.66 | 49.512B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.4 | 27.972B | ||
| VTRS | VIATRIS INC | 5.36 | 15.693B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.94 | 11.495B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.787B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.274B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.606B | ||
| CORT | CORCEPT THERAPEUTICS INC | 51.43 | 4.465B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CMND
Company Profile
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Company Info
IPO: 2021-08-10
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16042601566
CLEARMIND MEDICINE INC / CMND FAQ
What does CMND do?
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
What is the current price of CMND stock?
The current stock price of CMND is 1.08 USD.
Does CMND stock pay dividends?
CMND does not pay a dividend.
How is the ChartMill rating for CLEARMIND MEDICINE INC?
CMND has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is CMND stock listed?
CMND stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of CLEARMIND MEDICINE INC (CMND)?
CLEARMIND MEDICINE INC (CMND) does not have a PE ratio as the earnings reported over the last twelve months were negative (-24.4).